Gastroesophageal Reflux Disease in Azerbaijan

NCT03616119 | Completed

• 1 other identifier: QastroHep
• Study Type: observational
• Target: 1,000
• Locations: 1 country
• Sites: 1

Brief Summary

To evaluate the prevalence of Gastroesophageal reflux disease in Azerbaijan. It is intended to evaluate the prevalence of the disease in the regions as well as the capital by cluster sampling ,ethitology and to compare the outcomes depending on the geographical location.

Conditions

Gastroesophageal Reflux Disease

Keywords

gastoesophageal reflux disease; prevalence; Azerbaijan

Outcome Measures

Primary Outcomes (2)

• The prevalence of GERD in Azerbaijan

  The prevalence of GERD in Azerbaijan was 22.7% with significant female predominance (26.1% vs 15.3%; p\<0.0001). GERD was defined in 17 % for ages below 35; 22.7 % for 36-55 and 38.5 % for those who are above 56 that, accordingly, indicating that GERD becomes significant as age increases (p\<0.0001). Reflux was observed in 18.1% of normal weight respondents (BMI 18.6-24.9), 25.6% of overweight (BMI 25-29.9), and in 30.4% of obese (BMI\>30) individuals (p=0.001). Regarding marital status, the prevalence was the lowest in the single subjects' group (17%), close to average in the married group (23.8%), and the highest (41.7%) in divorced/widowed cases (p=0.003). Stress was significantly affecting GERD distribution, affecting 59.4% of all respondents (p\<0.004).

  1 year

• GERD questionnaire (GERD) of Mayo case 1998- 019

  Observational study

  1 year

Eligibility Criteria

• Age: 18 Years - 80 Years
• Gender Eligibility Details: 18-80 age range
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Azerbaijan is divided by clusters with a definite numbers of individuals to take survey on reflux disease in the given age range and calculated by proportion of males and females.

You may qualify if:

• Age: 18-80
• Both genders
• Hearburn
• Belching
• Regurgitation

You may not qualify if:

• protom pomp inhibitor use
• antibiotic use in the last 4 weeks
• upper GI surgery

Sponsors & Collaborators

• Sevda Aghayeva: lead
• Azerbaijan Medical University: collaborator

Study Sites (1)

Azerbaijan Gastroenterology and hepatology Association

Baku, Nasimi, AZ1018, Azerbaijan

Location

MeSH Terms

Conditions

Gastroesophageal Reflux

Condition Hierarchy (Ancestors)

Esophageal Motility Disorders; Deglutition Disorders; Esophageal Diseases; Gastrointestinal Diseases; Digestive System Diseases

Study Officials

• Sevda Aghayeva, MD

  Azerbaijan Gastroenterology and Hepatology Association

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Target Duration: 12 Months
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: principal investigator

Study Record Dates

• First Submitted: July 29, 2018
• First Posted: August 6, 2018
• Study Start: January 1, 2018
• Primary Completion: August 1, 2019
• Study Completion: September 1, 2019
• Last Updated: December 13, 2022

Record last verified: 2022-12

Locations

AZ (1)